Related Experiment Videos
Medicinal Cannabis in Orthopaedic Practice.
Lindsay T Kleeman-Forsthuber1, Douglas A Dennis, Jason M Jennings
1From the Porter Adventist Hospital, Denver, CO (Dr. Kleeman-Forsthuber, Dr. Dennis, and Dr. Jennings), the Department of Mechanical and Materials Engineering, Denver University, Denver, CO (Dr. Dennis and Dr. Jennings), the Department of Orthopaedics, University of Colorado School of Medicine, Denver, CO (Dr. Dennis), and the Department of Biomedical Engineering, University of Tennessee, Knoxville, TN (Dr. Dennis).
The Journal of the American Academy of Orthopaedic Surgeons
|December 5, 2019
Summary
Cannabis use is increasing in patients undergoing joint replacement surgery. Current evidence is limited, so more research is needed to confirm cannabis
Area of Science:
- Orthopaedic surgery
- Pain management
- Cannabinoid science
Background:
- Cannabis legalization has led to increased self-reported use among patients, including those undergoing primary total joint arthroplasty.
- The endocannabinoid system is implicated in inflammation and pain modulation, suggesting potential therapeutic benefits.
Purpose of the Study:
- To review the current evidence on cannabis use in orthopaedic patients.
- To assess the potential role of cannabis as a treatment or adjunct for musculoskeletal conditions.
Main Methods:
- Literature review of existing studies on cannabis and orthopaedic conditions.
- Analysis of self-reported cannabis use trends in primary total joint arthroplasty patients.
Main Results:
- Evidence regarding cannabis efficacy and safety in orthopaedics is currently limited.
- A notable increase in self-reported cannabis consumption has been observed in patients undergoing total joint arthroplasty.
Conclusions:
- The orthopaedic community is exploring cannabis for musculoskeletal conditions due to its proposed anti-inflammatory and analgesic properties.
- Insufficient evidence currently prevents recommendations for widespread cannabis use in orthopaedics.
- Further research is essential to establish the efficacy and safety of cannabis in this patient population before endorsement by surgeons.
Related Concept Videos
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
633
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
633
01:25Analgesia and Pain Management
1.4K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.4K
01:31Skeletal Muscle Relaxants: Therapeutic Uses
831
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
831
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
376
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
376
01:11Local Anesthetics: Clinical Application as Spinal Anesthesia
1.2K
Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...
1.2K